How can medicines help victims of a biological attack when vaccines are unavailable?

When vaccines are unavailable following a biological attack, medical systems rely on alternative treatments to help victims recover from exposure to biological agents.1

One primary medical intervention involves the use of antitoxins. These are antibodies capable of neutralizing specific toxins produced by bacteria. For medical use, these are often administered as an antiserum, which is a concentrated preparation derived from animals that have been exposed to the toxin. Antitoxins are currently utilized in the treatment of various serious conditions, including botulism, diphtheria, and tetanus.2

Beyond antitoxins, civil defense programs—such as the U.S. Strategic National Stockpile—maintain reserves of various medicines and emergency medical equipment to provide rapid support during a crisis. Ongoing research also focuses on developing supplements and therapies designed to enhance the recipient's immune system to better defend against a broad spectrum of potential biological warfare agents. These medical efforts are essential components of a broader civil defense strategy that includes triage, decontamination, and the use of protective equipment to mitigate the impact of an attack.13